Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination

Abstract Background This clinical trial evaluated a novel telomerase-targeting therapeutic cancer vaccine, UV1, in combination with ipilimumab, in patients with metastatic melanoma. Translational research was conducted on patient-derived blood and tissue samples with the goal of elucidating the effe...

Full description

Bibliographic Details
Main Authors:	Espen Basmo Ellingsen, Gergana Bounova, Iliana Kerzeli, Irantzu Anzar, Donjete Simnica, Elin Aamdal, Tormod Guren, Trevor Clancy, Artur Mezheyeuski, Else Marit Inderberg, Sara M. Mangsbo, Mascha Binder, Eivind Hovig, Gustav Gaudernack
Format:	Article
Language:	English
Published:	BMC 2022-09-01
Series:	Journal of Translational Medicine
Subjects:	Cancer Immunotherapy Therapeutic Cancer Vaccine Telomerase hTERT Melanoma
Online Access:	https://doi.org/10.1186/s12967-022-03624-z

Similar Items

382 The synthetic long peptide cancer vaccine UV1 in combination with ipilimumab induces a CD4+ Th1 anti-hTERT immune response and an inflammatory tumor microenvironment in patients with melanoma
by: Sara Mangsbo, et al.
Published: (2021-11-01)

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
by: Espen Basmo Ellingsen, et al.
Published: (2021-07-01)

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
by: Sara M Mangsbo, et al.
Published: (2022-05-01)

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
by: Vilde Drageset Haakensen, et al.
Published: (2021-05-01)

Human Telomerase Reverse Transcriptase (hTERT) expression in patients with Chronic Myelogenous Leukemia at defferent phases of the disease
by: A Amini, et al.
Published: (2008-09-01)

Targeting HMGB3/hTERT axis for radioresistance in cervical cancer
by: Zongjuan Li, et al.
Published: (2020-11-01)

Human Telomerase Reverse Transcriptase (hTERT) Expression in Patients with Chronic Myelogenous Leukemia at Different Phases of the Disease
by: K Alimoghadam, et al.
Published: (2008-08-01)

The hTERTα Splice Variant is a Dominant Negative Inhibitor of Telomerase Activity
by: Lorel M. Colgin, et al.
Published: (2000-09-01)

Effects of hTERT transfection on the telomere and telomerase of Periplaneta americana cells in vitro
by: Chenjing Ma, et al.
Published: (2023-10-01)

CDC5L Promotes hTERT Expression and Colorectal Tumor Growth
by: Jia Li, et al.
Published: (2017-05-01)

Effects of matrine on the growth inhibition, c-myc and hTERT protein expression in human adenocarcinoma lung cancer cell line A549
by: Qiong CHEN, et al.
Published: (2008-08-01)

Bufalin Inhibits hTERT Expression and Colorectal Cancer Cell Growth by Targeting CPSF4
by: Ningning Zhang, et al.
Published: (2016-12-01)

Spotlight on <i>hTERT</i> Complex Regulation in Cutaneous T-Cell Lymphomas
by: Joana Ropio, et al.
Published: (2023-02-01)

hTERT Downregulation Attenuates Resistance to DOX, Impairs FAK-Mediated Adhesion, and Leads to Autophagy Induction in Breast Cancer Cells
by: Aleksandra Romaniuk-Drapała, et al.
Published: (2021-04-01)

Expression of hTERT and Lp-PLA(2) genes is increased in primary hypothyroidism.
by: Seema Garg, et al.
Published: (2024-06-01)

RBFOX3 Promotes Gastric Cancer Growth and Progression by Activating HTERT Signaling
by: Chen Luo, et al.
Published: (2020-07-01)

Circulating tumor cells (CTCs) and hTERT gene expression in CTCs for radiotherapy effect with lung cancer
by: Ying Xu, et al.
Published: (2023-05-01)

hTERT Promotes CRC Proliferation and Migration by Recruiting YBX1 to Increase NRF2 Expression
by: Chunli Gong, et al.
Published: (2021-05-01)

Understanding the Interplay between COX-2 and hTERT in Colorectal Cancer Using a Multi-Omics Analysis
by: Georgios D. Ayiomamitis, et al.
Published: (2019-10-01)

FOXM1 increases hTERT protein stability and indicates poor prognosis in gastric cancer
by: Qingyun Tang, et al.
Published: (2023-02-01)

Mechanism of Human Telomerase Reverse Transcriptase (<i>hTERT</i>) Regulation and Clinical Impacts in Leukemia
by: Mot Yee Yik, et al.
Published: (2021-07-01)

Engineered CRISPR/Cas13d Sensing hTERT Selectively Inhibits the Progression of Bladder Cancer In Vitro
by: Chengle Zhuang, et al.
Published: (2021-03-01)

A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
by: Sólrún Melkorka Maggadóttir, et al.
Published: (2022-11-01)

Platelet-derived Microparticles Increase the Expression of hTERT Gene in Umbilical Cord Mesenchymal Stem Cells
by: Maryam Samareh Salavati Pour, et al.
Published: (2017-11-01)

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
by: Luigi Aurisicchio, et al.
Published: (2020-01-01)

Gene Expression Profile in Immortalized Human Periodontal Ligament Fibroblasts Through hTERT Ectopic Expression: Transcriptome and Bioinformatic Analysis
by: Lygia S. Nogueira, et al.
Published: (2021-06-01)

Mapping of the Gene for the Human Telomerase Reverse Transcriptase, hTERT, to Chromosome 5p15.33 by Fluorescence in Situ Hybridization
by: Lisa A. Bryce, et al.
Published: (2000-05-01)

hTERT-Driven Immortalization of RDEB Fibroblast and Keratinocyte Cell Lines Followed by Cre-Mediated Transgene Elimination
by: Nadezhda A. Evtushenko, et al.
Published: (2021-04-01)

The Role of Alternative RNA Splicing in the Regulation of <i>hTERT</i>, Telomerase, and Telomeres: Implications for Cancer Therapeutics
by: Aaron L. Slusher, et al.
Published: (2020-06-01)

Diagnostic value of methylated human telomerase reverse transcriptase (hTERT) in human cancers: a meta-analysis
by: Wei eGao, et al.
Published: (2015-12-01)

Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
by: Hasan Afzaal, et al.
Published: (2022-11-01)

Alternative Splicing of Human Telomerase Reverse Transcriptase (hTERT) and Its Implications in Physiological and Pathological Processes
by: Anna A. Plyasova, et al.
Published: (2021-05-01)

Establishing and characterizing human stem cells from the apical papilla immortalized by hTERT gene transfer
by: Qianyu Cheng, et al.
Published: (2023-05-01)

Evaluation of hTERT, KRT7, and survivin in urine for noninvasive detection of bladder cancer using real‐time PCR
by: Reza Yahyazadeh, et al.
Published: (2021-04-01)

Joint quantitative measurement of hTERT mRNA in both peripheral blood and circulating tumor cells of patients with nasopharyngeal carcinoma and its clinical significance
by: Xinsa Fu, et al.
Published: (2017-07-01)

Differential DNA Methylation of THOR and <i>hTAPAS</i> in the Regulation of <i>hTERT</i> and the Diagnosis of Cancer
by: Pauline Ott, et al.
Published: (2022-09-01)

Melatonin synergizes BRAF-targeting agent vemurafenib in melanoma treatment by inhibiting iNOS/hTERT signaling and cancer-stem cell traits
by: Jiaojiao Hao, et al.
Published: (2019-02-01)

The hTERT and hTERC Telomerase Gene Promoters Are Activated by the Second Exon of the Adenoviral Protein, E1 A, Identifying the Transcriptional Corepressor CtBP as a Potential Rearessor of Both Genes
by: Rosalind M. Glasspool, et al.
Published: (2005-06-01)

Blood-Derived Exosomal hTERT mRNA in Patients with Lung Cancer: Characterization and Correlation with Response to Therapy
by: Ofer Rotem, et al.
Published: (2023-06-01)

G-Quadruplex Formed by the Promoter Region of the <i>hTERT</i> Gene: Structure-Driven Effects on DNA Mismatch Repair Functions
by: Anzhela V. Pavlova, et al.
Published: (2022-08-01)